Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.89 -0.06 (-0.86%)
As of: Sep 4, 2026 · 1:35 PM EDT

Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023)

Ginkgo Bioworks Holdings' (DNA) quarterly Finished Goods came in at $4.4 million in Q2 2023, down 41.06% YoY from $7.5 million in Q2 2022, and down 16.26% on a QoQ basis from $5.3 million in Q1 2023.

Analysis

Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has 4 years of Finished Goods data on file, last reported at $4.4 million in Q2 2023.

  • Quarterly Finished Goods fell 41.06% year-over-year to $4.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $4.4 million (down 41.06% YoY) and the FY2022 annual result came in at $6.6 million, up 100.86% from the prior year.
  • Finished Goods slipped to $4.4 million in Q2 2023, from $5.3 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $8.0 million in Q1 2022 to a low of $2.5 million in Q3 2021.
  • A 4-year average of $5.1 million and a median of $5.3 million in 2023 frame the typical range for Finished Goods.
  • Annual changes were most pronounced in 2022 — Finished Goods soared 120.66% — and 2023, when it tumbled 41.06%.
  • Tracing DNA's Finished Goods over 4 years: stood at $2.8 million in 2020, then gained by 18.43% to $3.3 million in 2021, then soared by 100.86% to $6.6 million in 2022, then tumbled by 32.35% to $4.4 million in 2023.
  • The last three Finished Goods figures came in at $4.4 million (Q2 2023), $5.3 million (Q1 2023), and $6.6 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Ginkgo Bioworks Holdings 428.45 Mn 343.92 Mn 18.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 4.44 Mn
Mar 31, 2023 5.30 Mn
Dec 31, 2022 6.56 Mn
Sep 30, 2022 5.59 Mn
Jun 30, 2022 7.52 Mn
Mar 31, 2022 7.98 Mn
Dec 31, 2021 3.26 Mn
Sep 30, 2021 2.53 Mn
Dec 31, 2020 2.76 Mn